Phadia 2500EE 12-4100-02Recalls & reported problems
Phadia AB · Phadia 2500EE · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 0
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
No MAUDE adverse event reports in our data reference this device identifier directly.
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Recalls naming this device
- May 1, 2023Open, Classified
Higher reported results when running EliA GliadinDP IgG Well on the instruments Phadia 2500EE compared to running EliA GliadinDP IgG Well on Phadia 250 instrument
Z-2041-2023 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Other ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE (CCP) devices
- BioPlex 2200 6653250Bio-Rad Laboratories, Inc. · ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE (CCP)1 recall1 report
- Alinity 09P2720Abbott GmbH · ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE (CCP)1 recall0 reports
- IMMUNOSCAN CCPlus RA-96PLUSSvar Life Science AB · Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page